Synthomics (Acquired in 2020)

About:

Synthomics' DNA and RNA synthesizer cuts costs by a factor of 20-100x, increase throughput by a similar factor and decrease turnaround

Website: https://www.synthomics.com

Top Investors: Propel(X), CSC Upshot, Genoa Ventures, TSVC

Description:

Acquired 2020. Synthomics' distributed synthesis model places the power of DNA and RNA synthesis directly in the hands of the end-user. Leveraging multiple innovations in instrumentation and consumables, the technology empowers laboratories to fuel more rapid innovation in biological discovery.